Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

The Federal Deposit Insurance Corporation, or FDIC, said the number of banks included in 'Problem Bank List' of its Q4 2025 Quarterly Banking Profile increased by a net of three to 60. The report ...

Getting LeetCode onto your PC can make practicing coding problems a lot smoother. While there isn’t an official LeetCode app you can download and install like regular software, there are several ways ...

The city released a new list Wednesday highlighting property owners with repeated and severe housing violations. These range from rodent infestations to collapsed ceilings and buildings left vacant ...

Trying to get a handle on LeetCode problems without being constantly connected to the internet? It can be a bit tricky since LeetCode is an online-only platform. You ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

A comprehensive collection of LeetCode problem solutions implemented in C# .NET 8.0, organized by difficulty level and featuring comprehensive unit tests. This repository serves as both a reference ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...